Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus - Hammer, Fabian; Genser, Bernd; Dieplinger, Benjamin; Egger, Margot; Müller, Thomas; Drechsler, Christiane; März, Winfried; Störk, Stefan; Wanner, Christoph; Krane, Vera (Clinical kidney journal, 2022)
Gesehen am 25.09.2023